2024/12/21 更新

写真a

ミヤハラ ヒロユキ
宮原 宏幸
MIYAHARA Hiroyuki
所属
医歯薬学域 講師(特任)
職名
講師(特任)
外部リンク

学位

  • 博士 ( 2023年3月   岡山大学 )

 

論文

  • Trabecular bone scores in children with osteogenesis imperfecta respond differently to bisphosphonate treatment depending on disease severity

    Natsuko Futagawa, Kosei Hasegawa, Hiroyuki Miyahara, Hiroyuki Tanaka, Hirokazu Tsukahara

    Frontiers in Pediatrics   12   2024年12月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Frontiers Media SA  

    Introduction

    Osteogenesis imperfecta (OI) is a congenital skeletal disorder characterized by bone fragility. Bisphosphonates (BISs) have become the mainstream treatment in children with OI. However, an optimal treatment protocol has not yet been established, while BIS treatment tends to be administered to normalize bone mineral density (BMD). Bone quality is an important component of bone strength. The trabecular bone score (TBS) is a quantitative measure of the microstructure that affects bone quality. This study investigated the TBS during BIS treatment in children with OI.

    Materials and methods

    Twenty-nine children with OI were enrolled and classified into two groups: mild (type 1) and moderate to severe (types 3 and 4). Dual-energy x-ray absorptiometry images were retrospectively analyzed for TBS calculation. The relationship between the areal BMD (aBMD), its Z-score, height-adjusted BMD (BMDHAZ) Z-score, TBS, and TBS Z-score with the treatment duration was assessed for each group.

    Results

    In the mild group, the aBMD, its Z-score, and BMDHAZ Z-score showed a significant positive correlation with treatment duration (r = 0.68, 0.68, 0.72, respectively, p < 0.01). The TBS Z-score tended to increase with treatment duration, albeit without reaching significance. In the moderate to severe group, the TBS Z-score showed a significant positive correlation with treatment duration (r = 0.48, p < 0.01), in contrast to the aBMD Z-score, which did not increase. Finally, the BMDHAZ Z-score only showed a weak positive correlation with treatment duration (r = 0.37, p < 0.01).

    Conclusion

    Because BIS affect the BMD and TBS differently based on the severity of OI, treatment goals may need to be stratified by disease severity.

    DOI: 10.3389/fped.2024.1500023

    researchmap

  • 後頭部可逆性白質脳症を合併した肢端紅痛症の1例

    武川 真也, 鈴木 健吾, 宇田 和宏, 茂原 研司, 荒川 恭佑, 齋藤 有希惠, 宮原 宏幸, 長谷川 高誠, 小原 隆史, 塚原 紘平, 八代 将登, 津下 充, 塚原 宏一

    日本小児科学会雑誌   128 ( 7 )   1004 - 1005   2024年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本小児科学会  

    researchmap

  • Radiological characteristics of skeletal growth in neonates and infants with achondroplasia. 国際誌

    Daisuke Miyahara, Kosei Hasegawa, Yuko Ago, Natsuko Futagawa, Hiroyuki Miyahara, Yousuke Higuchi, Kazuki Yamada, Tomonori Tetsunaga, Tadashi Moriwake, Hiroyuki Tanaka, Hirokazu Tsukahara

    American journal of medical genetics. Part A   2023年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Achondroplasia (ACH) is the most common form of skeletal dysplasia characterized by a rhizomelic short stature. Radiological skeletal findings in pediatric and adult patients with ACH include short long bones, a relatively longer fibula compared to the tibia, a narrow lumbar interpedicular distance, and a hypoplastic iliac wing. Nonetheless, the characteristics of skeletal growth during the neonatal and infantile periods have scarcely been explored. Therefore, this retrospective study aimed to analyze the radiological skeletal growth during the neonatal and infantile periods in 41 Japanese patients with genetically confirmed ACH. The length of long bones in the upper and lower limbs and the lumbar interpedicular distances at L1 and L4 were measured. These parameters showed significant positive correlations with age. The upper segment-to-lower segment ratio in the lower limbs resembled the data of healthy controls from previous reports. The L1/L4 and fibula/tibia ratios increased with age, suggesting that some representative skeletal phenotypes of ACH were less distinct during the neonatal and infantile periods. In conclusion, for the first time, this study radiologically characterized skeletal growth during the neonatal and infantile periods of patients with genetically confirmed ACH.

    DOI: 10.1002/ajmg.a.63525

    PubMed

    researchmap

  • Novel and recurrent COMP gene variants in five Japanese patients with pseudoachondroplasia: skeletal changes from the neonatal to infantile periods.

    Kosei Hasegawa, Natsuko Futagawa, Yuko Ago, Hiroyuki Miyahara, Daisuke Harada, Mari Miyazawa, Junko Yoshimoto, Kenji Baba, Tadashi Moriwake, Hiroyuki Tanaka, Hirokazu Tsukahara

    Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology   32 ( 4 )   221 - 227   2023年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Pseudoachondroplasia (PSACH) is an autosomal dominant skeletal dysplasia caused by pathogenic variants of cartilage oligomeric matrix protein (COMP). Clinical symptoms of PSACH are characterized by growth disturbances after the first year of life. These disturbances lead to severe short stature with short limbs, brachydactyly, scoliosis, joint laxity, joint pain since childhood, and a normal face. Epimetaphyseal dysplasia, shortened long bones, and short metacarpals and phalanges are common findings on radiological examination. Additionally, anterior tonguing of the vertebral bodies in the lateral view is an important finding in childhood because it is specific to PSACH and normalizes with age. Here, we report five Japanese patients with PSACH, with one recurrent (p.Cys351Tyr) and four novel heterozygous pathogenic COMP variants (p.Asp437Tyr, p.Asp446Gly, p.Asp507Tyr, and p.Asp518Val). These five pathogenic variants were located in the calcium-binding type 3 (T3) repeats. In four of the novel variants, the affected amino acid was aspartic acid, which is abundant in each of the eight T3 repeats. We describe the radiological findings of these five patients. We also retrospectively analyzed the sequential changes in the vertebral body and epimetaphysis of the long bones from the neonatal to infantile periods in a patient with PSACH and congenital heart disease.

    DOI: 10.1297/cpe.2023-0035

    PubMed

    researchmap

  • 新生児領域における酸化ストレス制御の意義

    塚原 宏一, 宮原 宏幸, 鷲尾 洋介, 津下 充, 馬場 健児

    日本小児高血圧研究会誌   18 ( 1 )   10 - 18   2022年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本小児高血圧研究会  

    酸化ストレスは、内部・外部刺激により生体内で活性酸素群(活性窒素も含む)が抗酸化システムで捕捉しきれないほど過剰に生じる状況である。酸化ストレス亢進は血管内皮障害と深く関連する。とりわけ、血管内皮での一酸化窒素(nitric oxide:NO)生成は生体のレドックス環境を保持するうえで必須である。酸化ストレス亢進はarginineを基質とするNO合成を抑制し、内因性NO合成酵素阻害因子であるasymmetric dimethylarginine(ADMA)の生成を刺激する。新生児の急速進行性疾患、慢性遷延性疾患ではしばしば酸化ストレスが増幅され、生体の構造や機能が酸化劣化を受けて、組織障害が不可逆的に進展する。これらの疾患の治療や管理において酸化ストレスを制御することは重要である。そのためには酸化ストレスの病態生理、それへの防御機制を把握し、特異的マーカーを用いて患者の酸化ストレス環境を非~低侵襲的に評価することが必要である。新生児医療の現場で実施される種々の治療は、酸化ストレス制御を目指すものでもある。その中で、母乳はNO、thioredoxin-1などの抗酸化因子を多量に含有し、酸化ストレス過剰病態の抑止に有効と推定される。今後は、"レドックス"に関連してより特異性の高い細胞機能修飾薬が開発され、それらが重症疾患への集学治療の中に組み込まれていくことが期待される。(著者抄録)

    researchmap

  • Author Correction: Thioredoxin interacting protein protects mice from fasting induced liver steatosis by activating ER stress and its downstream signaling pathways. 国際誌

    Hiroyuki Miyahara, Kosei Hasegawa, Masato Yashiro, Toshiaki Ohara, Masayoshi Fujisawa, Teizo Yoshimura, Akihiro Matsukawa, Hirokazu Tsukahara

    Scientific reports   12 ( 1 )   8026 - 8026   2022年5月

     詳細を見る

  • Thioredoxin interacting protein protects mice from fasting induced liver steatosis by activating ER stress and its downstream signaling pathways. 国際誌

    Hiroyuki Miyahara, Kosei Hasegawa, Masato Yashiro, Toshiaki Ohara, Masayoshi Fujisawa, Teizo Yoshimura, Akihiro Matsukawa, Hirokazu Tsukahara

    Scientific reports   12 ( 1 )   4819 - 4819   2022年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Under normal conditions, fasting results in decreased protein disulfide isomerase (PDI) activity and accumulation of unfolded proteins, leading to the subsequent activation of the unfolded protein response (UPR)/autophagy signaling pathway to eliminate damaged mitochondria. Fasting also induces upregulation of thioredoxin-interacting protein (TXNIP) expression and mice deficient of this protein (TXNIP-KO mice) was shown to develop severe hypoglycemia, hyperlipidemia and liver steatosis (LS). In the present study, we aimed to determine the role of TXNIP in fasting-induced LS by using male TXNIP-KO mice that developed LS without severe hypoglycemia. In TXNIP-KO mice, fasting induced severe microvesicular LS. Examinations by transmission electron microscopy revealed mitochondria with smaller size and deformities and the presence of few autophagosomes. The expression of β-oxidation-associated genes remained at the same level and the level of LC3-II was low. PDI activity level stayed at the original level and the levels of p-IRE1 and X-box binding protein 1 spliced form (sXBP1) were lower. Interestingly, treatment of TXNIP-KO mice with bacitracin, a PDI inhibitor, restored the level of LC3-II after fasting. These results suggest that TXNIP regulates PDI activity and subsequent activation of the UPR/autophagy pathway and plays a protective role in fasting-induced LS.

    DOI: 10.1038/s41598-022-08791-z

    PubMed

    researchmap

  • Urinary Protein-to-creatinine Ratios Predict Recurrence in Pediatric and Young Adult Cases of Minimal Change Nephrotic Syndrome.

    Hiroyuki Miyahara, Takayuki Miyai, Kunihiko Aya, Hirokazu Tsukahara

    Acta medica Okayama   76 ( 1 )   41 - 49   2022年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    High-dose steroids are required for the treatment of minimal change nephrotic syndrome (MCNS), especially for episodes of recurrence. Predicting and avoiding recurrence can help reduce the steroid dose, but prediction is currently difficult. We herein examined whether changes in laboratory data, especially the urinary protein- to-creatinine ratio (UTP/UCr), can predict clinical recurrence. We also assessed differences in clinical features between children and young adults. We included 36 patients with MCNS; for each case, we retrospectively studied laboratory data during stable remission and pre-recurrence, with the "stable" period defined as all but the 6 weeks before recurrence, and pre-recurrence defined as the 4±2 weeks before recurrence. UTP/UCr, serum albumin, etc. were measured every 5 years during stable periods. We divided patients into cohorts by age at recurrence, < 15 years and ≥ 15 years, and compared stable and pre-recurrence values for the two groups. UTP/UCr values during stable periods tended to be higher in younger patients. UTP/UCr and serum albumin showed statistically significant changes during pre-recurrence periods, but only in those aged ≥ 15 years. Thus, clinical features of recurrence differed depending on age. Signs of recurrence can be confirmed via UTP/UCr or serum albumin several weeks before recurrence in patients ≥ 15 years.

    DOI: 10.18926/AMO/63207

    PubMed

    researchmap

  • SLEにおけるTAC、MMF併用中の下痢と急性腎障害

    奥村 美紗, 宮原 宏幸, 茂原 研司, 斎藤 有希恵, 津下 充, 八代 将登, 塚原 宏一

    小児科診療   85 ( 2 )   253 - 255   2022年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)診断と治療社  

    症例は全身性エリテマトーデスの18歳女性。タクロリムス(TAC)、ミコフェノール酸モフェチル(MMF)併用下に寛解状態にあった。急性胃腸炎を機に腎機能が低下し、いったん軽快した下痢の再燃および血球減少を認めた。TAC、MMF相互の副作用により両薬剤の血中濃度が上昇し有害事象が出現したと考えられ、TAC減量により症状は改善した。TAC、MMF2剤併用中に胃腸炎に罹患したときには、特異な血中濃度の変動に注意する必要がある。(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/default/link?pub_year=2022&ichushi_jid=J00642&link_issn=&doc_id=20220119040018&doc_link_id=%2Fae4shond%2F2022%2F008502%2F019%2F0253-0255%26dl%3D0&url=https%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fae4shond%2F2022%2F008502%2F019%2F0253-0255%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

  • A novel pathogenic variant p.Asp797Val in IFIH1 in a Japanese boy with overlapping Singleton-Merten syndrome and Aicardi-Goutières syndrome. 国際誌

    Kosei Hasegawa, Hiroyuki Tanaka, Natsuko Futagawa, Hiroyuki Miyahara, Yousuke Higuchi, Hirokazu Tsukahara

    American journal of medical genetics. Part A   188 ( 1 )   249 - 252   2022年1月

     詳細を見る

    記述言語:英語  

    Pathogenic-activating variants of interferon induced with Helicase C domain 1 (IFIH1) cause Singleton-Merten (S-M) syndrome, which accompanies acro-osteolysis, loss of permanent teeth, and aortic calcification, as well as causing Aicardi-Goutières (A-G) syndrome, which shows progressive encephalopathy, spastic paraplegia, and calcification of basal ganglia. Recently, patients with overlapping syndromes presenting with features of S-M syndrome and A-G syndrome were reported. However, progression of clinical features of this condition has not been fully understood. We report a Japanese boy with a novel pathogenic IFIH1 variant who presented with clinical features of S-M syndrome and A-G syndrome.

    DOI: 10.1002/ajmg.a.62478

    PubMed

    researchmap

  • Rapid Progression of Heterotopic Ossification in Severe Variant of Fibrodysplasia Ossificans Progressiva with p.Arg258Gly in ACVR1: A Case Report and Review of Clinical Phenotypes. 国際誌

    Kosei Hasegawa, Hiroyuki Tanaka, Natsuko Futagawa, Hiroyuki Miyahara, Hirokazu Tsukahara

    Case reports in genetics   2022   5021758 - 5021758   2022年

     詳細を見る

    記述言語:英語  

    Fibrodysplasia ossificans progressiva (FOP) is a rare skeletal disorder characterized by congenital malformation of the great toes and progressive heterotopic ossification. Malformation of the great toes appears at birth, while heterotopic ossification generally occurs during childhood and rarely occurs during infancy. Classical FOP results from the heterozygous p.Arg206His variant of the ACVR1 gene, which encodes Activin A receptor type 1. Recently, some atypical FOP patients with other ACVR1 gene variants and clinical features that are not observed in classical FOP patients have been reported. Herein, we describe a girl with severe FOP and multiple anomalies, including syndactyly of the hands and feet, nail agenesis, mandibular hypoplasia, heterotopic ossification occurring from infancy, and congenital cardiac malformation. In our patient, we identified de novo occurrence of the heterozygous p.Arg258Gly variant of ACVR1, which has previously been reported in only two severe FOP patients. Heterotopic ossification occurred earlier and more frequently compared with classical FOP patients. We present the time-series changes in heterotopic ossification in our patient and compare her clinical features with those of the previously reported patients with p.Arg258Gly. Our report deepens understanding of the clinical features in severe FOP with p.Arg258Gly and of FOP as a systemic disorder.

    DOI: 10.1155/2022/5021758

    PubMed

    researchmap

  • Laboratory changes during adrenocorticotropic hormone therapy associated with renal calcified lesions. 国際誌

    Hiroyuki Miyahara, Tomoyuki Akiyama, Kosei Hasegawa, Mari Akiyama, Makio Oka, Katsuhiro Kobayashi, Hirokazu Tsukahara

    Pediatrics international : official journal of the Japan Pediatric Society   62 ( 5 )   587 - 592   2020年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Renal calcified lesions are known as one of the complications during adrenocorticotropic hormone (ACTH) therapy for intractable epilepsy. However, laboratory changes during the therapy or laboratory features of high-risk cases with renal calcified lesions are yet to be clarified. METHODS: In this study, 43 patients with West syndrome aged ≤2 years were included. We retrospectively reviewed age and body mass index at the beginning of ACTH therapy, as well as the amount of fluid intake, daily urinary volume, and laboratory data during therapy. In addition, we studied the urinary sediment of the cases with renal calcified lesions diagnosed by computed tomography. RESULTS: After initiating ACTH treatment, urinary calcium (Ca)/creatinine ratio and urinary pH increased within 2 weeks. Urinary crystals and renal tubular epithelial cells (RTECs) in urinary sediment were frequently found in most cases. Urinary Ca levels, proteinuria or frequency of urinary crystals, and number of RTECs in the urinary sediment were significantly higher in patients with epithelial casts (ECs) or hematuria than in patients without these findings. Among the seven patients who underwent abdominal CT, ECs or hematuria were found only in those with renal calcified lesions. These findings suggested that patients with ECs or hematuria were more likely to have calcified lesions. CONCLUSIONS: The risk of renal calcified lesions increased after 2 weeks of ACTH treatment. Abnormal findings in urinary sediments might be an early sign of renal calcification during ACTH therapy.

    DOI: 10.1111/ped.14158

    PubMed

    researchmap

  • Vitamin B6 in acute encephalopathy with biphasic seizures and late reduced diffusion. 国際誌

    Tomoyuki Akiyama, Soichiro Toda, Nobusuke Kimura, Yukiko Mogami, Yoshiyuki Hanaoka, Chiho Tokorodani, Tomoshiro Ito, Hiroyuki Miyahara, Yuki Hyodo, Katsuhiro Kobayashi

    Brain & development   42 ( 5 )   402 - 407   2020年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: The initial presentation of acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) is indistinguishable from that of complex febrile seizures (FS), which poses a great diagnostic challenge for clinicians. Excitotoxicity is speculated to be the pathogenesis of AESD. Vitamin B6 (VB6) is essential for the biosynthesis of gamma-aminobutyric acid, an inhibitory neurotransmitter. The aim of this study is to investigate our hypothesis that VB6 deficiency in the brain may play a role in AESD. METHODS: We obtained cerebrospinal fluid (CSF) samples from pediatric patients with AESD after early seizures and those with FS. We measured pyridoxal 5'-phosphate (PLP) and pyridoxal (PL) concentrations in the CSF samples using high-performance liquid chromatography with fluorescence detection. RESULTS: The subjects were 5 patients with AESD and 17 patients with FS. Age did not differ significantly between AESD and FS. In AESD, CSF PLP concentration was marginally lower (p = 0.0999) and the PLP-to-PL ratio was significantly (p = 0.0417) reduced compared to those in FS. CONCLUSIONS: Although it is impossible to conclude that low PLP concentration and PLP-to-PL ratio are causative of AESD, this may be a risk factor for developing AESD. When combined with other markers, this finding may be useful in distinguishing AESD from FS upon initial presentation.

    DOI: 10.1016/j.braindev.2020.02.002

    PubMed

    researchmap

  • マルチターゲット療法で加療中、胃腸炎を機に急性腎障害に至った全身性エリテマトーデスの一例

    宮原 宏幸, 石井 雅人, 茂原 研司, 津下 充, 八代 将登, 塚原 宏一

    日本小児腎臓病学会雑誌   33 ( 1 )   106 - 106   2020年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本小児腎臓病学会  

    researchmap

  • Chemoradiotherapy for Unresectable INI1-negative Chordoma in a Child. 国際誌

    Hiroyuki Miyahara, Seishiro Nodomi, Katsutsugu Umeda, Satoshi Itasaka, Kenji Waki, Tsuyoshi Imai

    Journal of pediatric hematology/oncology   42 ( 1 )   65 - 68   2020年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The characteristics of chordomas in children are distinct from those in adults. In particular, the prognosis of patients with INI1-negative chordoma is dismal. The standard treatment for localized chordoma, complete surgical resection with a wide margin, is seldom feasible for chordomas arising at the clivus in children, mainly due to associated complications. Therefore, other treatments for unresectable chordomas in children, including chemoradiotherapy, must be explored. Here, we report a 7-year-old girl with an INI1-negative chordoma of the clivus, who responded to conventional chemotherapy plus radiotherapy. Without surgical resection, she remains alive after 1 year and 7 months of the initial diagnosis.

    DOI: 10.1097/MPH.0000000000001318

    PubMed

    researchmap

  • Differential diagnosis of nonepileptic twilight state with convulsive manifestations after febrile seizures. 国際誌

    Hiroyuki Miyahara, Tomoyuki Akiyama, Kenji Waki, Yoshio Arakaki

    Brain & development   40 ( 9 )   781 - 785   2018年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Nonepileptic twilight state with convulsive manifestations (NETC) is a nonepileptic state following a febrile seizure (FS), which may be misdiagnosed as a prolonged seizure and result in overtreatment. We aimed to describe clinical manifestations of NETC and to determine characteristics that are helpful to distinguish NETC from other pathological conditions. METHODS: We conducted a retrospective chart review from January 2010 to December 2016 and selected the patients who presented with symptoms resembling status epilepticus with fever and a confirmed diagnosis using an electroencephalogram (EEG). We compared the NETC clinical features and venous blood gas analysis results with those of other conditions that mimic NETC. We also compared the characteristics of NETC with past reports. RESULTS: Our NETC patients presented with short durations of the preceding generalized convulsions followed by tonic posturing, closed eyes, no cyanosis, responsiveness to painful stimulation, and no accumulation of CO2 in the venous blood gas. Most of these characteristics were consistent with past reports. Prolonged FS or acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) showed several of these features, but all the characteristics were not consistent with our study. CONCLUSIONS: Prolonged FS and AESD need to be differentiated from NETC, and close clinical observation makes it possible to partially distinguish NETC from the other conditions. EEG is recommended for patients with symptoms that are inconsistent with these features.

    DOI: 10.1016/j.braindev.2018.05.014

    PubMed

    researchmap

  • Recurrent Meningitis in an 11-year-old Girl with a Petrous Apex Cystic Lesion.

    Hiroyuki Miyahara, Hironobu Tokumasu, Masaki Chin, Kenji Waki, Yoshio Arakaki

    Acta medica Okayama   72 ( 5 )   519 - 523   2018年10月

     詳細を見る

    記述言語:英語  

    Cases of recurrent meningitis in elderly patients with a spontaneous cerebrospinal fistula have been reported, and in some of these patients, cystic lesions were thought to be the underlying cause. We report a case of recurrent meningitis in an 11-year-old Japanese girl with an arachnoid cyst in the petrous apex. Pulsation of the cystic lesion was thought to cause bone erosion, leading to the formation of a fistula. Magnetic resonance imaging was useful in evaluating the arachnoid cyst and fistula. During 2 years of follow-up, the osteolytic lesion enlarged and the rate of bone erosion was higher than expected.

    DOI: 10.18926/AMO/56251

    PubMed

    researchmap

  • A Japanese case of hereditary chin trembling responsive to arotinolol. 国際誌

    Tomoyuki Akiyama, Hiroyuki Miyahara, Kenji Waki, Harumi Yoshinaga, Katsuhiro Kobayashi

    Parkinsonism & related disorders   29   133 - 4   2016年8月

     詳細を見る

  • Changes in the features of invasive pneumococcal disease after introduction of the seven-valent pneumococcal conjugate vaccine in a regional core hospital of Kochi, Japan.

    Hiroyuki Miyahara, Hidehiko Maruyama, Akane Kanazawa, Yuka Iwasaki, Yusuke Shigemitsu, Hirokazu Watanabe, Chiho Tokorodani, Mari Miyazawa, Yusei Nakata, Ritsuo Nishiuchi, Kiyoshi Kikkawa

    Acta medica Okayama   69 ( 4 )   255 - 60   2015年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Since the introduction of the seven-valent pneumococcal conjugate vaccine (PCV7) in 2007, invasive pneumococcal disease has declined, but the incidence of Streptococcus pneumoniae serotype 19A has risen worldwide. The present study examined changes in the features of invasive pneumococcal disease since the introduction of the PCV7 in Kochi, Japan. Pediatric cases of invasive pneumococcal disease were investigated before and after vaccine introduction (January 2008 to December 2013). Cases of invasive pneumococcal disease tended to decrease after PCV7 introduction. In addition, before introduction of the vaccine, most serotypes causing invasive pneumococcal disease were those included in the vaccine. However, after the introduction, we found cases infected by serotypes not covered by vaccine. Penicillin-resistant S. pneumoniae was the predominant serotype causing invasive pneumococcal disease before introduction of the PCV7, and the susceptibility of this serotype to antibiotics improved after vaccine introduction. Serotype isolates identified after vaccine introduction were also relatively susceptible to antibiotic therapy, but decreased susceptibility is expected.

    PubMed

    researchmap

▼全件表示

MISC

  • 【周産期医学必修知識(第9版)】血中リン異常

    塚原 宏一, 宮原 宏幸, 馬場 健児

    周産期医学   51 ( 増刊 )   883 - 885   2021年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)東京医学社  

    researchmap

  • 【小児疾患診療のための病態生理2 改訂第6版】腎・泌尿器疾患 腎・尿路結石

    宮原 宏幸, 塚原 宏一

    小児内科   53 ( 増刊 )   598 - 600   2021年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)東京医学社  

    researchmap

  • ステロイド使用中のネフローゼ症候群における骨微細構造の検討

    宮原 宏幸, 宮井 貴之, 二川 奈都子, 宮原 大輔, 長谷川 高誠, 塚原 宏一

    日本腎臓学会誌   63 ( 4 )   500 - 500   2021年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本腎臓学会  

    researchmap

  • ステロイド使用中のネフローゼ症候群における骨微細構造の評価

    宮原 宏幸, 宮井 貴之, 二川 奈都子, 長谷川 高誠, 宮原 大輔, 塚原 宏一

    日本小児腎臓病学会雑誌   34 ( 1Suppl. )   137 - 137   2021年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本小児腎臓病学会  

    researchmap

  • X染色体性の遺伝形式が示唆されるが原因遺伝子が不明なDent病の兄弟例

    宮井 貴之, 宮原 宏幸, 片山 寿夫, 高岩 正典, 田中 弘之, 塚原 宏一

    日本小児腎臓病学会雑誌   33 ( 1 )   95 - 95   2020年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本小児腎臓病学会  

    researchmap

  • ACTH療法中に尿路結石を生じた乳幼児例における尿沈渣所見の経時的変化

    宮原 宏幸, 水野 むつみ, 兵頭 勇紀, 西本 静香, 花岡 義行, 松田 奈央子, 金 聖泰, 柴田 敬, 遠藤 文香, 秋山 麻里, 岡 牧郎, 秋山 倫之, 小林 勝弘, 塚原 宏一

    日本小児科学会雑誌   123 ( 7 )   1199 - 1199   2019年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本小児科学会  

    researchmap

  • 精神発達遅滞を伴った小児にウルトラロングカテーテルを用いて腹膜透析を導入した1例

    宮井 貴之, 宮原 宏幸, 笠原 由美子, 野田 卓男, 塚原 宏一, 田中 弘之

    日本小児腎不全学会雑誌   39   250 - 252   2019年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本小児腎不全学会  

    精神発達遅滞を伴った小児には、身体にテープを貼られたりカテーテルを留置されたりすることを拒絶する者がおり、腹膜透析(peritoneal dialysis:PD)の導入に難渋することがある。成人領域では認知症を伴った高齢者に肩甲骨部出口でPDを導入する報告がある。精神発達遅滞を伴う末期腎不全の小児に対し、工夫してPDを導入した症例を報告する。ジュベール症候群の男児が15歳で末期腎不全に至りPDを行って献腎移植を待機する方針を選択した。出口部保清を保つため肩甲骨部出口を採用し、ウルトラロングカテーテルを留置し、良好な注排液が得られた。この2点の工夫が精神発達遅滞を伴った小児におけるPD導入時の問題を軽減し、これまで導入をあきらめていた例でもPDが腎代替療法の選択肢になりうることが示唆された。(著者抄録)

    researchmap

▼全件表示

共同研究・競争的資金等の研究

  • 小児重症急性腎障害の病態解析と新規治療法の開発~生体マーカーを基軸として~

    研究課題/領域番号:19K08277  2019年04月 - 2022年03月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    塚原 宏一, 宮原 宏幸

      詳細を見る

    配分額:3770000円 ( 直接経費:2900000円 、 間接経費:870000円 )

    小児ICUで管理される重症患者は容易に急性腎障害あるいは急性腎不全を発症する。今回の研究では、多臓器障害、心臓発生異常、呼吸器・アレルギー疾患、川崎病、IgA血管炎、腎結石症など腎臓合併症を呈しえる疾患を有する小児患者を対象に、生体応答で中核をなすレドックス制御(酸化ストレス・ニトロ化ストレス)、血管内皮機能を特異的生体マーカー計測によって検討した。これらの疾患において、それらが原疾患や合併症によって複合的に障害されていること、その病態生理の解明と継続的な生体マーカー計測が新たな治療方略につながることが結論された。

    researchmap

 

担当授業科目

  • 周産期・新生児(基本臨床実習) (2024年度) 特別  - その他

  • 小児科学・小児神経学(基本臨床実習) (2024年度) 特別  - その他

  • 選択制臨床実習(小児科学) (2024年度) 特別  - その他